Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

This study has been completed.

Study NCT00197249 Information provided by GlaxoSmithKline

First Received: September 15, 2005 Last Updated: November 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2005
Primary Completion Date:	June 2003 (Final data collection date for primary outcome measure)